Vinita Gupta
Tracked across 3 events · 32 articles · First seen Apr 02, 2026 · Last active Aug 21, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
Impact: As CEO of Lupin, Vinita Gupta announced the spin-out, highlighting the company's commitment to oncology innovation.
Jul 21, 2026 · 7 articles
Business
Lupin (company)'s wholly-owned subsidiary VISUfarma has entered into an exclusive licensing agreement with Visus Therapeutics Inc., a wholly-owned subsidiary of Tenpoint Therapeutics Holding Limited, to commercialize YUVEZZI, a once-daily eye drop for presbyopia, in the…
Impact: As CEO of Lupin, Vinita Gupta publicly endorsed the partnership, highlighting its strategic importance for the company's vision care franchise and specialty care strategy.
Aug 20, 2026 · 12 articles
Business
Impact: Vinita Gupta, CEO of Lupin (company), commented on the acquisition, highlighting its strategic importance for Lupin (company)'s specialty care portfolio and European expansion.
Apr 02, 2026 · 13 articles
ERGEN INTELLIGENCE
Track Vinita Gupta live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard